BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15236661)

  • 1. Polypharmacy in psychiatric practice in the Canary Islands.
    De las Cuevas C; Sanz EJ
    BMC Psychiatry; 2004 Jul; 4():18. PubMed ID: 15236661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Polypharmacy in psychiatric patients as an alternative to limited mental health resources].
    de las Cuevas C; Sanz EJ; de la Fuente JA; Cueto M
    Actas Esp Psiquiatr; 2005; 33(2):81-6. PubMed ID: 15768314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National trends in psychotropic medication polypharmacy in office-based psychiatry.
    Mojtabai R; Olfson M
    Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences and psychotropic polypharmacy in psychiatric patients in Brazil: a cross-sectional analysis of the PESSOAS Project.
    Costa JO; Ceccato MDGB; Melo APS; Acurcio FA; Guimarães MDC
    Cad Saude Publica; 2017 May; 33(4):e00168915. PubMed ID: 28538794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.
    Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M
    Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The definition and prevalence of pediatric psychotropic polypharmacy.
    Chen H; Patel A; Sherer J; Aparasu R
    Psychiatr Serv; 2011 Dec; 62(12):1450-5. PubMed ID: 22193792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotropic drugs prescriptions in Al-Qassim region, Saudi Arabia.
    al-Ghamdy YS; Qureshi NA; Abdelghadir MH; al-Habeeb TA; Ahmad SA
    East Mediterr Health J; 1999 Jan; 5(1):27-34. PubMed ID: 10793778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of drug monotherapy in psychiatric inpatient treatment.
    Rittmannsberger H
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):547-51. PubMed ID: 11999906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: A comparison with other psychiatric disorders.
    Bridler R; Häberle A; Müller ST; Cattapan K; Grohmann R; Toto S; Kasper S; Greil W
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):763-72. PubMed ID: 25907249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychotropic drugs prescription at two regional psychiatric hospitals in northern Nigeria.
    Adeponle AB; Obembe AO; Nnaji F; Adeyemi SO; Suleiman GT
    West Afr J Med; 2008 Apr; 27(2):106-10. PubMed ID: 19025025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotropic polypharmacy for the treatment of bipolar disorder in Taiwan.
    Hung GC; Yang SY; Chen Y; Lin SK
    Psychiatr Serv; 2014 Jan; 65(1):125-8. PubMed ID: 24382766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polypharmacy in psychiatric treatment. Patterns of psychotropic drug use in Austrian psychiatric clinics.
    Rittmannsberger H; Meise U; Schauflinger K; Horvath E; Donat H; Hinterhuber H
    Eur Psychiatry; 1999 Mar; 14(1):33-40. PubMed ID: 10572323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survey of off-label prescribing for inpatients with mild intellectual disability and mental illness.
    Haw C; Stubbs J
    J Intellect Disabil Res; 2005 Nov; 49(Pt 11):858-64. PubMed ID: 16207284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug prescription in Italian Residential Facilities].
    Tomasi R; de Girolamo G; Santone G; Picardi A; Micciolo R; Semisa D; Fava S;
    Epidemiol Psichiatr Soc; 2005; 14(2):77-90. PubMed ID: 16001704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prescribing of psychotropic drugs in mental health services in Trinidad.
    Moore S; Jaime LK; Maharajh H; Ramtahal I; Reid S; Ramsewak FS; Maharaj M
    Rev Panam Salud Publica; 2002 Sep; 12(3):207-14. PubMed ID: 12396640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern of psychotropic prescription in a tertiary care center: a critical analysis.
    Sarkar P; Chakraborty K; Misra A; Shukla R; Swain SP
    Indian J Pharmacol; 2013; 45(3):270-3. PubMed ID: 23833371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychotropic Polypharmacy in Patients with Dementia: Prevalence and Predictors.
    Nørgaard A; Jensen-Dahm C; Gasse C; Hansen ES; Waldemar G
    J Alzheimers Dis; 2017; 56(2):707-716. PubMed ID: 28035931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polypharmacy in psychiatry: a multi-state comparison of psychotropic drug combinations.
    Sheppard C; Beyel V; Fracchia J; Merlis S
    Dis Nerv Syst; 1974 Apr; 35(4):183-9. PubMed ID: 17894114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypharmacy among psychiatric patients.
    Hemminki E
    Acta Psychiatr Scand; 1977 Nov; 56(5):347-56. PubMed ID: 339670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.